title: Hepatitis C.
abstract: In the latter half of the 20th century, HCV emerged as the most common cause of chronic liver disease, and will likely remain so. Since its initial discovery in 1989, rapid progress has been made in our understanding of the virology, epidemiology, natural history, diagnosis, and treatment of HCV. Over the next few decades, as further advancements are made, superior treatment options will become available.
authors.affiliation: Harvard Medical School, Division of Gastroenterology, Boston, Massachusetts, USA.
authors.forename: C P
authors.initials: CP
authors.lastname: Cheney
authors.forename: S
authors.initials: S
authors.lastname: Chopra
authors.forename: C
authors.initials: C
authors.lastname: Graham
mesh_terms: D000998:Antiviral Agents / Q000627:therapeutic use*; D003937:Diagnosis, Differential; D016174:Hepacivirus / Q000145:classification* / Q000235:genetics / Q000276:immunology; D006526:Hepatitis C / Q000175:diagnosis / Q000453:epidemiology / Q000209:etiology / Q000628:therapy; D018937:Hepatitis C Antibodies / Q000032:analysis; D006801:Humans; D015995:Prevalence
chemical_list: D000998:Antiviral Agents; D018937:Hepatitis C Antibodies